Skip to content
★ Sign in to follow
DC

Dawn Carter Bir

Directeur Commercial
Reata Pharmaceuticals IncSoleno Therapeutics Inc
Total declarations
24
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€23.4M

Latest filing published 09 Jun 2025 for Soleno Therapeutics INC.

Filing timeline

BuySale
Dawn Carter Bir

Insider track record

Disclosed buys
0
Disclosed sells
14

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Dawn Carter Bir: trading record in brief

Dawn Carter Bir, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Reata Pharmaceuticals Inc and Soleno Therapeutics Inc. Over a trading history stretching from 9 November 2020 to 5 June 2025, the count stands at 24 filings.

The open-market record consists of 14 sales worth €23.4M, with no purchase. Besides market trades, the filings include 5 share grants.

On 9 June 2025 came the latest disclosure, a share grant in Soleno Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Dawn Carter Bir

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total

13 of 13 declarations